SlideShare uma empresa Scribd logo
1 de 8
Defibrillation Strategies for Refractory
Ventricular Fibrillation
TRIAL NAME-DOSE VF TRAIL
PUBLISHED IN NEJM NOV 24-2022
FUNDING: Supported by the Heart and Stroke
Foundation of Canada Grant-in-Aid program.
BACKGOUND
• Despite advances in defibrillation technology, shock-refractory
ventricular fibrillation remains common during out-of-hospital
cardiac arrest
• More than 350,000 unexpected deaths each year in North America
• Antiarrhythmic medications such as amiodarone and lidocaine have
been used to prevent refibrillation, neither drug has been definitively
shown to improve survival to hospital discharge or neurologically
intact survival
Objective
Compare two novel therapeutic defibrillation strategies (DSED and
vector change defibrillation) against standard practice for patients
remaining in refractory VF during out-of-hospital cardiac arrest.
• Double sequential external defibrillation (DSED), the technique of
providing rapid sequential shocks from two defibrillators with
defibrillation pads placed in two different planes (anterior– lateral
and anterior–posterior)
• Vector-change (VC) defibrillation, the technique of switching
defibrillation pads from the anterior–lateral to the anterior–posterior
position
• Research Question: Among adult (≥ 18 years) patients
presenting in refractory VF or pulseless ventricular tachycardia (pVT)
during out-of-hospital cardiac arrest, does DSED or vector change
defibrillation (anterior-posterior compared to anterior-anterior pad
position) result in greater rates of survival to hospital discharge
compared to standard defibrillation.
• Inclusion Criteria:
 ≥18 years of age
 non-traumatic cardiac arrest of presumed cardiac etiology,
 presenting rhythm of ventricular fibrillation/pVT; with no ROSC or
non VF rhythm after three consecutive shocks separated by 2-minute
intervals of cardiopulmonary resuscitation(CPR)
• Intervention:
(1) Resuscitation involving DSED, or
(2) Resuscitation involving vector change defibrillation (anterior-anterior
compared to anterior-posterior pad position).
Exclusion Criteria:
 Traumatic cardiac arrest,
 patients with pre-existing do not resuscitate orders,
 presumed pregnancy,
 patients in recurrent ventricular fibrillation (defined as those with a
secondary presentation of VF (not the presenting rhythm) or those
presenting in VF but did not receive three consecutive defibrillation
attempts).
 Patient’s whose initial care was provided by non-participating EMS
agencies or fire services.
Outcomes
PRIMARY OUTCOME :
 survival to hospital discharge.
SECONDARY OUTCOMES
 ROSC
 termination of VF after the first interventional shock,
 termination of VF inclusive of all interventional shocks,
 and number of defibrillation attempts to obtain ROSC.
Methods
Study Design and Population:
1. three-arm, cluster randomized trial with crossover conducted in six regions of Ontario,
Canada (Peel, Halton, Toronto, Simcoe, London and Ottawa) from March 2018 through May
2022.
2. Two treatment strategies (DSED and vector change) simultaneously assessed against a
common control group (standard defibrillation).
Patient Recruitment and Randomization
• Randomization was performed at the level of the paramedic service. Random treatment
sequences were computer-generated by the coordinating center before the start of the
trial.
• Each cluster (paramedic service) crossed over every 6 months to one of the three treatment
groups (standard defibrillation, VC defibrillation, or DSED).
• During the trial, each service had to cross over to each of the treatment groups at least once
• Trial Protocol and Intervention
 provincial protocol consistent with American Heart Association
guidelines
 Continuous chest compressions were performed before application
of the defibrillator pads.
 rhythm analysis occurred at standard 2-minute intervals
 the first three defibrillation attempts occurred with defibrillation
pads placed in the anterior–lateral position (standard defibrillation)
 after three consecutive shocks, three types of defibrillation

Mais conteúdo relacionado

Semelhante a Defibrillation Strategies for Refractory.pptx

C.R.T - Wireless L.V Endocardial Pacing - The SELECT - LV study
C.R.T - Wireless L.V Endocardial Pacing  - The SELECT - LV studyC.R.T - Wireless L.V Endocardial Pacing  - The SELECT - LV study
C.R.T - Wireless L.V Endocardial Pacing - The SELECT - LV studyNarra Sandeep
 
Cardiology Journal club
Cardiology Journal clubCardiology Journal club
Cardiology Journal clubPRAVEEN GUPTA
 
IImplantable Cardioverter Defibrillators (ICDs) - Dr Prithvi puwar
IImplantable Cardioverter Defibrillators (ICDs) - Dr Prithvi puwarIImplantable Cardioverter Defibrillators (ICDs) - Dr Prithvi puwar
IImplantable Cardioverter Defibrillators (ICDs) - Dr Prithvi puwarPrithvi Puwar
 
Should we implant icd only in some patients with nicmp (cons)
Should we implant icd only in some patients with nicmp (cons)Should we implant icd only in some patients with nicmp (cons)
Should we implant icd only in some patients with nicmp (cons)Alireza Ghorbani Sharif
 
Guidelines for dvt prophylaxis in surgical patients
Guidelines for dvt prophylaxis in surgical patientsGuidelines for dvt prophylaxis in surgical patients
Guidelines for dvt prophylaxis in surgical patientsLajpat Rai
 
Meta analysis of percutaneous ventricular restoration (pvr) therapy using the...
Meta analysis of percutaneous ventricular restoration (pvr) therapy using the...Meta analysis of percutaneous ventricular restoration (pvr) therapy using the...
Meta analysis of percutaneous ventricular restoration (pvr) therapy using the...Cardio Kinetix
 
INCIDENCIA DE COMPLICACIONES RELACIONADAS A CATETER
INCIDENCIA DE COMPLICACIONES RELACIONADAS A CATETER INCIDENCIA DE COMPLICACIONES RELACIONADAS A CATETER
INCIDENCIA DE COMPLICACIONES RELACIONADAS A CATETER Itzumy Rodríguez Calderón
 
Classification and Regression Tree Analysis in Biomedical Research
Classification and Regression Tree Analysis in Biomedical Research Classification and Regression Tree Analysis in Biomedical Research
Classification and Regression Tree Analysis in Biomedical Research Salford Systems
 
Current best practice of cvad
Current best practice of cvadCurrent best practice of cvad
Current best practice of cvadTarek Kotb
 
B. introducing observation medicine for emergency medicine physicians power p...
B. introducing observation medicine for emergency medicine physicians power p...B. introducing observation medicine for emergency medicine physicians power p...
B. introducing observation medicine for emergency medicine physicians power p...Sangil Lee
 
FIBRILACION AURICULAR EN URGENCIAS THE After Study
FIBRILACION AURICULAR EN URGENCIAS  THE After StudyFIBRILACION AURICULAR EN URGENCIAS  THE After Study
FIBRILACION AURICULAR EN URGENCIAS THE After Studyjasar
 
Clinical guidelines for kidney transplantation 0
Clinical guidelines for kidney  transplantation 0Clinical guidelines for kidney  transplantation 0
Clinical guidelines for kidney transplantation 0FarragBahbah
 

Semelhante a Defibrillation Strategies for Refractory.pptx (20)

C.R.T - Wireless L.V Endocardial Pacing - The SELECT - LV study
C.R.T - Wireless L.V Endocardial Pacing  - The SELECT - LV studyC.R.T - Wireless L.V Endocardial Pacing  - The SELECT - LV study
C.R.T - Wireless L.V Endocardial Pacing - The SELECT - LV study
 
Cardiology Journal club
Cardiology Journal clubCardiology Journal club
Cardiology Journal club
 
Covid 19 (1)
Covid 19 (1)Covid 19 (1)
Covid 19 (1)
 
Covid 19 (1)
Covid 19 (1)Covid 19 (1)
Covid 19 (1)
 
Covid 19 (1)
Covid 19 (1)Covid 19 (1)
Covid 19 (1)
 
IImplantable Cardioverter Defibrillators (ICDs) - Dr Prithvi puwar
IImplantable Cardioverter Defibrillators (ICDs) - Dr Prithvi puwarIImplantable Cardioverter Defibrillators (ICDs) - Dr Prithvi puwar
IImplantable Cardioverter Defibrillators (ICDs) - Dr Prithvi puwar
 
Covid 19
Covid 19Covid 19
Covid 19
 
Should we implant icd only in some patients with nicmp (cons)
Should we implant icd only in some patients with nicmp (cons)Should we implant icd only in some patients with nicmp (cons)
Should we implant icd only in some patients with nicmp (cons)
 
Guidelines for dvt prophylaxis in surgical patients
Guidelines for dvt prophylaxis in surgical patientsGuidelines for dvt prophylaxis in surgical patients
Guidelines for dvt prophylaxis in surgical patients
 
Meta analysis of percutaneous ventricular restoration (pvr) therapy using the...
Meta analysis of percutaneous ventricular restoration (pvr) therapy using the...Meta analysis of percutaneous ventricular restoration (pvr) therapy using the...
Meta analysis of percutaneous ventricular restoration (pvr) therapy using the...
 
Ppt dawn trial
Ppt dawn trialPpt dawn trial
Ppt dawn trial
 
Defer stemi
Defer stemiDefer stemi
Defer stemi
 
Strive Teleconf Presentation Feb14 2007
Strive Teleconf Presentation Feb14 2007Strive Teleconf Presentation Feb14 2007
Strive Teleconf Presentation Feb14 2007
 
Vte prophylaxis
Vte prophylaxisVte prophylaxis
Vte prophylaxis
 
INCIDENCIA DE COMPLICACIONES RELACIONADAS A CATETER
INCIDENCIA DE COMPLICACIONES RELACIONADAS A CATETER INCIDENCIA DE COMPLICACIONES RELACIONADAS A CATETER
INCIDENCIA DE COMPLICACIONES RELACIONADAS A CATETER
 
Classification and Regression Tree Analysis in Biomedical Research
Classification and Regression Tree Analysis in Biomedical Research Classification and Regression Tree Analysis in Biomedical Research
Classification and Regression Tree Analysis in Biomedical Research
 
Current best practice of cvad
Current best practice of cvadCurrent best practice of cvad
Current best practice of cvad
 
B. introducing observation medicine for emergency medicine physicians power p...
B. introducing observation medicine for emergency medicine physicians power p...B. introducing observation medicine for emergency medicine physicians power p...
B. introducing observation medicine for emergency medicine physicians power p...
 
FIBRILACION AURICULAR EN URGENCIAS THE After Study
FIBRILACION AURICULAR EN URGENCIAS  THE After StudyFIBRILACION AURICULAR EN URGENCIAS  THE After Study
FIBRILACION AURICULAR EN URGENCIAS THE After Study
 
Clinical guidelines for kidney transplantation 0
Clinical guidelines for kidney  transplantation 0Clinical guidelines for kidney  transplantation 0
Clinical guidelines for kidney transplantation 0
 

Mais de purraSameer

IEC PROTOCOL DR SAMEER PURRA CARDIOLOGY.ppt
IEC PROTOCOL DR SAMEER PURRA CARDIOLOGY.pptIEC PROTOCOL DR SAMEER PURRA CARDIOLOGY.ppt
IEC PROTOCOL DR SAMEER PURRA CARDIOLOGY.pptpurraSameer
 
31273_coarctation of aorta; catheter interventions icc 2008.ppt
31273_coarctation of aorta; catheter interventions icc 2008.ppt31273_coarctation of aorta; catheter interventions icc 2008.ppt
31273_coarctation of aorta; catheter interventions icc 2008.pptpurraSameer
 
acls/blsCARDIO PULMONARY RESUSITATION.pptx
acls/blsCARDIO PULMONARY RESUSITATION.pptxacls/blsCARDIO PULMONARY RESUSITATION.pptx
acls/blsCARDIO PULMONARY RESUSITATION.pptxpurraSameer
 
CARDIAC AMYLOIDOSIS a brief review – sameer.pptx
CARDIAC AMYLOIDOSIS a brief review – sameer.pptxCARDIAC AMYLOIDOSIS a brief review – sameer.pptx
CARDIAC AMYLOIDOSIS a brief review – sameer.pptxpurraSameer
 
catherterization study for DM residentsCath study.pptx
catherterization study for DM residentsCath study.pptxcatherterization study for DM residentsCath study.pptx
catherterization study for DM residentsCath study.pptxpurraSameer
 
multivalvular heart disease AS, MR WITH PDA.pptx
multivalvular heart disease AS, MR WITH PDA.pptxmultivalvular heart disease AS, MR WITH PDA.pptx
multivalvular heart disease AS, MR WITH PDA.pptxpurraSameer
 
clinical and angiographic profilr of armed force personnel presenting as acs....
clinical and angiographic profilr of armed force personnel presenting as acs....clinical and angiographic profilr of armed force personnel presenting as acs....
clinical and angiographic profilr of armed force personnel presenting as acs....purraSameer
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptxpurraSameer
 
1588923212-infective-endocarditis.ppt
1588923212-infective-endocarditis.ppt1588923212-infective-endocarditis.ppt
1588923212-infective-endocarditis.pptpurraSameer
 
ENVIRONMENT AND CARDIOVASCULAR DISEASE.pptx
ENVIRONMENT AND CARDIOVASCULAR DISEASE.pptxENVIRONMENT AND CARDIOVASCULAR DISEASE.pptx
ENVIRONMENT AND CARDIOVASCULAR DISEASE.pptxpurraSameer
 
DR sameer acess.pptx
DR sameer acess.pptxDR sameer acess.pptx
DR sameer acess.pptxpurraSameer
 
MORTALITY MEET.pptx
MORTALITY MEET.pptxMORTALITY MEET.pptx
MORTALITY MEET.pptxpurraSameer
 
Empagliflozin in acute myocardial infarction.pptx
Empagliflozin in acute myocardial infarction.pptxEmpagliflozin in acute myocardial infarction.pptx
Empagliflozin in acute myocardial infarction.pptxpurraSameer
 

Mais de purraSameer (14)

IEC PROTOCOL DR SAMEER PURRA CARDIOLOGY.ppt
IEC PROTOCOL DR SAMEER PURRA CARDIOLOGY.pptIEC PROTOCOL DR SAMEER PURRA CARDIOLOGY.ppt
IEC PROTOCOL DR SAMEER PURRA CARDIOLOGY.ppt
 
31273_coarctation of aorta; catheter interventions icc 2008.ppt
31273_coarctation of aorta; catheter interventions icc 2008.ppt31273_coarctation of aorta; catheter interventions icc 2008.ppt
31273_coarctation of aorta; catheter interventions icc 2008.ppt
 
acls/blsCARDIO PULMONARY RESUSITATION.pptx
acls/blsCARDIO PULMONARY RESUSITATION.pptxacls/blsCARDIO PULMONARY RESUSITATION.pptx
acls/blsCARDIO PULMONARY RESUSITATION.pptx
 
CARDIAC AMYLOIDOSIS a brief review – sameer.pptx
CARDIAC AMYLOIDOSIS a brief review – sameer.pptxCARDIAC AMYLOIDOSIS a brief review – sameer.pptx
CARDIAC AMYLOIDOSIS a brief review – sameer.pptx
 
catherterization study for DM residentsCath study.pptx
catherterization study for DM residentsCath study.pptxcatherterization study for DM residentsCath study.pptx
catherterization study for DM residentsCath study.pptx
 
multivalvular heart disease AS, MR WITH PDA.pptx
multivalvular heart disease AS, MR WITH PDA.pptxmultivalvular heart disease AS, MR WITH PDA.pptx
multivalvular heart disease AS, MR WITH PDA.pptx
 
clinical and angiographic profilr of armed force personnel presenting as acs....
clinical and angiographic profilr of armed force personnel presenting as acs....clinical and angiographic profilr of armed force personnel presenting as acs....
clinical and angiographic profilr of armed force personnel presenting as acs....
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
1588923212-infective-endocarditis.ppt
1588923212-infective-endocarditis.ppt1588923212-infective-endocarditis.ppt
1588923212-infective-endocarditis.ppt
 
ENVIRONMENT AND CARDIOVASCULAR DISEASE.pptx
ENVIRONMENT AND CARDIOVASCULAR DISEASE.pptxENVIRONMENT AND CARDIOVASCULAR DISEASE.pptx
ENVIRONMENT AND CARDIOVASCULAR DISEASE.pptx
 
DR sameer acess.pptx
DR sameer acess.pptxDR sameer acess.pptx
DR sameer acess.pptx
 
MORTALITY MEET.pptx
MORTALITY MEET.pptxMORTALITY MEET.pptx
MORTALITY MEET.pptx
 
FLAVOUR TRIAL
FLAVOUR TRIALFLAVOUR TRIAL
FLAVOUR TRIAL
 
Empagliflozin in acute myocardial infarction.pptx
Empagliflozin in acute myocardial infarction.pptxEmpagliflozin in acute myocardial infarction.pptx
Empagliflozin in acute myocardial infarction.pptx
 

Último

Field exchange, Issue 72 April 2024 FEX-72.pdf
Field exchange, Issue 72 April 2024 FEX-72.pdfField exchange, Issue 72 April 2024 FEX-72.pdf
Field exchange, Issue 72 April 2024 FEX-72.pdfMohamed Miyir
 
Latest Dr Ranjit Jagtap News In Healthcare Field
Latest Dr Ranjit Jagtap News In Healthcare  FieldLatest Dr Ranjit Jagtap News In Healthcare  Field
Latest Dr Ranjit Jagtap News In Healthcare FieldDr Ranjit Jagtap
 
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...The Lifesciences Magazine
 
FAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptxFAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptxMumux Mirani
 
Learn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental FogginessLearn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental Fogginessbkling
 
Globalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od DoveGlobalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od Doveagatadrynko
 
Back care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationBack care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationpratiksha ghimire
 
Understanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdfUnderstanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdfSasikiranMarri
 
Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...mauryashreya478
 
Enhancing Health Through Personalized Nutrition
Enhancing Health Through Personalized NutritionEnhancing Health Through Personalized Nutrition
Enhancing Health Through Personalized NutritionNeighborhood Trainer
 
Incentive spirometry powerpoint presentation
Incentive spirometry powerpoint presentationIncentive spirometry powerpoint presentation
Incentive spirometry powerpoint presentationpratiksha ghimire
 
Immediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursingImmediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursingNursing education
 
Leading big change: what does it take to deliver at large scale?
Leading big change: what does it take to deliver at large scale?Leading big change: what does it take to deliver at large scale?
Leading big change: what does it take to deliver at large scale?HelenBevan4
 
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTS
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTSSARS Cov-2 INFECTION AND ITS EMERGING VARIANTS
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTSNehaSaini499770
 
Evidence-based resources -2023-PRUH SS.pptx
Evidence-based resources -2023-PRUH SS.pptxEvidence-based resources -2023-PRUH SS.pptx
Evidence-based resources -2023-PRUH SS.pptxMrs S Sen
 
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书rnrncn29
 
2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology InsightsHealth Catalyst
 
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdfeurohealthleaders
 

Último (20)

Dr Sujit Chatterjee Hiranandani Hospital Kidney.pdf
Dr Sujit Chatterjee Hiranandani Hospital Kidney.pdfDr Sujit Chatterjee Hiranandani Hospital Kidney.pdf
Dr Sujit Chatterjee Hiranandani Hospital Kidney.pdf
 
Field exchange, Issue 72 April 2024 FEX-72.pdf
Field exchange, Issue 72 April 2024 FEX-72.pdfField exchange, Issue 72 April 2024 FEX-72.pdf
Field exchange, Issue 72 April 2024 FEX-72.pdf
 
Latest Dr Ranjit Jagtap News In Healthcare Field
Latest Dr Ranjit Jagtap News In Healthcare  FieldLatest Dr Ranjit Jagtap News In Healthcare  Field
Latest Dr Ranjit Jagtap News In Healthcare Field
 
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
 
FAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptxFAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptx
 
Learn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental FogginessLearn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental Fogginess
 
Globalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od DoveGlobalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od Dove
 
Back care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationBack care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentation
 
Understanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdfUnderstanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdf
 
Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...
 
Enhancing Health Through Personalized Nutrition
Enhancing Health Through Personalized NutritionEnhancing Health Through Personalized Nutrition
Enhancing Health Through Personalized Nutrition
 
DELIRIUM psychiatric delirium is a organic mental disorder
DELIRIUM  psychiatric  delirium is a organic mental disorderDELIRIUM  psychiatric  delirium is a organic mental disorder
DELIRIUM psychiatric delirium is a organic mental disorder
 
Incentive spirometry powerpoint presentation
Incentive spirometry powerpoint presentationIncentive spirometry powerpoint presentation
Incentive spirometry powerpoint presentation
 
Immediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursingImmediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursing
 
Leading big change: what does it take to deliver at large scale?
Leading big change: what does it take to deliver at large scale?Leading big change: what does it take to deliver at large scale?
Leading big change: what does it take to deliver at large scale?
 
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTS
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTSSARS Cov-2 INFECTION AND ITS EMERGING VARIANTS
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTS
 
Evidence-based resources -2023-PRUH SS.pptx
Evidence-based resources -2023-PRUH SS.pptxEvidence-based resources -2023-PRUH SS.pptx
Evidence-based resources -2023-PRUH SS.pptx
 
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书
 
2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights
 
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
 

Defibrillation Strategies for Refractory.pptx

  • 1. Defibrillation Strategies for Refractory Ventricular Fibrillation TRIAL NAME-DOSE VF TRAIL PUBLISHED IN NEJM NOV 24-2022 FUNDING: Supported by the Heart and Stroke Foundation of Canada Grant-in-Aid program.
  • 2. BACKGOUND • Despite advances in defibrillation technology, shock-refractory ventricular fibrillation remains common during out-of-hospital cardiac arrest • More than 350,000 unexpected deaths each year in North America • Antiarrhythmic medications such as amiodarone and lidocaine have been used to prevent refibrillation, neither drug has been definitively shown to improve survival to hospital discharge or neurologically intact survival
  • 3. Objective Compare two novel therapeutic defibrillation strategies (DSED and vector change defibrillation) against standard practice for patients remaining in refractory VF during out-of-hospital cardiac arrest. • Double sequential external defibrillation (DSED), the technique of providing rapid sequential shocks from two defibrillators with defibrillation pads placed in two different planes (anterior– lateral and anterior–posterior) • Vector-change (VC) defibrillation, the technique of switching defibrillation pads from the anterior–lateral to the anterior–posterior position
  • 4. • Research Question: Among adult (≥ 18 years) patients presenting in refractory VF or pulseless ventricular tachycardia (pVT) during out-of-hospital cardiac arrest, does DSED or vector change defibrillation (anterior-posterior compared to anterior-anterior pad position) result in greater rates of survival to hospital discharge compared to standard defibrillation. • Inclusion Criteria:  ≥18 years of age  non-traumatic cardiac arrest of presumed cardiac etiology,  presenting rhythm of ventricular fibrillation/pVT; with no ROSC or non VF rhythm after three consecutive shocks separated by 2-minute intervals of cardiopulmonary resuscitation(CPR)
  • 5. • Intervention: (1) Resuscitation involving DSED, or (2) Resuscitation involving vector change defibrillation (anterior-anterior compared to anterior-posterior pad position). Exclusion Criteria:  Traumatic cardiac arrest,  patients with pre-existing do not resuscitate orders,  presumed pregnancy,  patients in recurrent ventricular fibrillation (defined as those with a secondary presentation of VF (not the presenting rhythm) or those presenting in VF but did not receive three consecutive defibrillation attempts).  Patient’s whose initial care was provided by non-participating EMS agencies or fire services.
  • 6. Outcomes PRIMARY OUTCOME :  survival to hospital discharge. SECONDARY OUTCOMES  ROSC  termination of VF after the first interventional shock,  termination of VF inclusive of all interventional shocks,  and number of defibrillation attempts to obtain ROSC.
  • 7. Methods Study Design and Population: 1. three-arm, cluster randomized trial with crossover conducted in six regions of Ontario, Canada (Peel, Halton, Toronto, Simcoe, London and Ottawa) from March 2018 through May 2022. 2. Two treatment strategies (DSED and vector change) simultaneously assessed against a common control group (standard defibrillation). Patient Recruitment and Randomization • Randomization was performed at the level of the paramedic service. Random treatment sequences were computer-generated by the coordinating center before the start of the trial. • Each cluster (paramedic service) crossed over every 6 months to one of the three treatment groups (standard defibrillation, VC defibrillation, or DSED). • During the trial, each service had to cross over to each of the treatment groups at least once
  • 8. • Trial Protocol and Intervention  provincial protocol consistent with American Heart Association guidelines  Continuous chest compressions were performed before application of the defibrillator pads.  rhythm analysis occurred at standard 2-minute intervals  the first three defibrillation attempts occurred with defibrillation pads placed in the anterior–lateral position (standard defibrillation)  after three consecutive shocks, three types of defibrillation